General Information of Disease (ID: DISE0ICN)

Disease Name Autosomal recessive limb-girdle muscular dystrophy type 2C
Synonyms
limb-girdle muscular dystrophy, type 2C; Dmda; sarcoglycan, gamma, deficiency of; limb-girdle muscular dystrophy with gamma-sarcoglycan deficiency; muscular dystrophy, Duchenne-like; severe childhood autosomal recessive muscular dystrophy, North African type; Duchenne-like muscular dystrophy, autosomal recessive, type 1; Adhalin deficiency, secondary; DMDA1; SCARMD; SGCG autosomal recessive limb-girdle muscular dystrophy; muscular dystrophy, limb-girdle, type 2C; severe childhood autosomal recessive muscular dystrophy North African type; LGMD2C; Maghrebian myopathy; autosomal recessive limb-girdle muscular dystrophy type 2C; deficiency of sarcoglycan gamma; muscular dystrophy, limb-girdle, autosomal recessive 5; autosomal recessive Duchenne-like muscular dystrophy type 1; gamma-sarcoglycanopathy; limb-girdle muscular dystrophy due to gamma-sarcoglycan deficiency; autosomal recessive limb-girdle muscular dystrophy caused by mutation in SGCG
Definition
Autosomal recessive limb-girdle muscular dystrophy type 2C (LGMD2C) is a subtype of autosomal recessive limb-girdle muscular dystrophy characterized by a childhood onset of progressive shoulder and pelvic girdle muscle weakness and atrophy frequently associated with calf hypertrophy, diaphragmatic weakness, and/or variable cardiac abnormalities. Mild to moderate elevated serum creatine kinase levels and positive Gowers sign are reported.
Disease Hierarchy
DISBHDU9: Familial dilated cardiomyopathy
DISGA5FN: Qualitative or quantitative defects of gamma-sarcoglycan
DISWPGLM: Autosomal recessive limb-girdle muscular dystrophy
DISE0ICN: Autosomal recessive limb-girdle muscular dystrophy type 2C
Disease Identifiers
MONDO ID
MONDO_0009677
MESH ID
C535900
UMLS CUI
C0410173
OMIM ID
253700
MedGen ID
98045
Orphanet ID
353

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 5 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
DMD TTWLFXU moderate Biomarker [1]
DYSF TTA7MXQ Strong Altered Expression [2]
SGCG TTSMT9W Strong Genetic Variation [3]
SGCA TTS9Q5V Definitive Biomarker [1]
SGCG TTSMT9W Definitive Autosomal recessive [4]
------------------------------------------------------------------------------------
This Disease Is Related to 4 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CAPN3 OTCHG3YK Strong Biomarker [5]
LAMA2 OTFROQWE Strong Genetic Variation [2]
SSPN OTYG2SL7 Strong Biomarker [6]
SGCG OTOLWHIQ Definitive Autosomal recessive [4]
------------------------------------------------------------------------------------

References

1 Severe gamma-sarcoglycanopathy caused by a novel missense mutation and a large deletion.Neuromuscul Disord. 2000 Feb;10(2):100-7. doi: 10.1016/s0960-8966(99)00063-2.
2 Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.Methods Mol Biol. 2018;1828:79-90. doi: 10.1007/978-1-4939-8651-4_5.
3 Impact of PYROXD1 deficiency on cellular respiration and correlations with genetic analyses of limb-girdle muscular dystrophy in Saudi Arabia and Sudan.Physiol Genomics. 2018 Nov 1;50(11):929-939. doi: 10.1152/physiolgenomics.00036.2018. Epub 2018 Aug 31.
4 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
5 Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G.Am J Med Genet. 1999 Feb 19;82(5):392-8. doi: 10.1002/(sici)1096-8628(19990219)82:5<392::aid-ajmg7>3.0.co;2-0.
6 Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions.Hum Mol Genet. 2000 Aug 12;9(13):2019-27. doi: 10.1093/hmg/9.13.2019.